These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30868675)

  • 41. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
    Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
    PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells.
    Zhao Z; Zhang L; Yao Q; Tao Z
    Cancer Gene Ther; 2015 Apr; 22(3):108-14. PubMed ID: 25721211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
    Zhang MC; Hu CP; Chen Q
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells.
    Pan QZ; Pan K; Wang QJ; Weng DS; Zhao JJ; Zheng HX; Zhang XF; Jiang SS; Lv L; Tang Y; Li YQ; He J; Liu Q; Chen CL; Zhang HX; Xia JC
    Stem Cells; 2015 Feb; 33(2):354-66. PubMed ID: 25267273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulatory mechanisms of annexin-induced chemotherapy resistance in cisplatin resistant lung adenocarcinoma.
    Wang C; Xiao Q; Li YW; Zhao C; Jia N; Li RL; Cao SS; Cui J; Wang L; Wu Y; Wen AD
    Asian Pac J Cancer Prev; 2014; 15(7):3191-4. PubMed ID: 24815469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway.
    Huang G; Lou T; Pan J; Ye Z; Yin Z; Li L; Cheng W; Cao Z
    Aging (Albany NY); 2019 Apr; 11(7):2138-2150. PubMed ID: 30981205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis.
    Hsu YL; Hung JY; Chiang SY; Jian SF; Wu CY; Lin YS; Tsai YM; Chou SH; Tsai MJ; Kuo PL
    Oncotarget; 2016 May; 7(19):27584-98. PubMed ID: 27050278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SNHG7 mediates cisplatin-resistance in non-small cell lung cancer by activating PI3K/AKT pathway.
    Chen K; Abuduwufuer A; Zhang H; Luo L; Suotesiyali M; Zou Y
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6935-6943. PubMed ID: 31486493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CNOT3 contributes to cisplatin resistance in lung cancer through inhibiting RIPK3 expression.
    Jing L; Zhai ME; Cui J; Fan XY; Cheng YY; Jiang JL; Chen ZN
    Apoptosis; 2019 Aug; 24(7-8):673-685. PubMed ID: 31177396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor-Host Feedback Signaling.
    Kamer I; Daniel-Meshulam I; Zadok O; Bab-Dinitz E; Perry G; Feniger-Barish R; Perelman M; Barshack I; Ben-Nun A; Onn A; Bar J
    Mol Cancer Res; 2020 Jun; 18(6):926-937. PubMed ID: 32169890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic carcinoma-associated fibroblasts promote an adaptative response in colorectal cancer cells that inhibit proliferation and apoptosis: nonresistant cells die by nonapoptotic cell death.
    Berdiel-Acer M; Bohem ME; López-Doriga A; Vidal A; Salazar R; Martínez-Iniesta M; Santos C; Sanjuan X; Villanueva A; Molleví DG
    Neoplasia; 2011 Oct; 13(10):931-46. PubMed ID: 22028619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR-424-3p and targeting PTEN/PI3K/Akt pathway.
    Lu C; Wang H; Chen S; Yang R; Li H; Zhang G
    J Cell Mol Med; 2018 Apr; 22(4):2478-2487. PubMed ID: 29392841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. mir-1-mediated paracrine effect of cancer-associated fibroblasts on lung cancer cell proliferation and chemoresistance.
    Li J; Guan J; Long X; Wang Y; Xiang X
    Oncol Rep; 2016 Jun; 35(6):3523-31. PubMed ID: 27035564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stress-induced upregulation of TNFSF4 in cancer-associated fibroblast facilitates chemoresistance of lung adenocarcinoma through inhibiting apoptosis of tumor cells.
    Li Y; Chen Y; Miao L; Wang Y; Yu M; Yan X; Zhao Q; Cai H; Xiao Y; Huang G
    Cancer Lett; 2021 Jan; 497():212-220. PubMed ID: 33132120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
    Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
    Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-21 in cancer-associated fibroblasts supports lung adenocarcinoma progression.
    Kunita A; Morita S; Irisa TU; Goto A; Niki T; Takai D; Nakajima J; Fukayama M
    Sci Rep; 2018 Jun; 8(1):8838. PubMed ID: 29892003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
    Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
    Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
    Huang RS; Zheng YL; Zhao J; Chun X
    Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential impact of fibroblasts on the efficient cell death of lung cancer cells induced by paclitaxel and cisplatin.
    Bartling B; Hofmann HS; Silber RE; Simm A
    Cancer Biol Ther; 2008 Aug; 7(8):1250-61. PubMed ID: 18487950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer.
    Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ
    Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.